Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033

Description

Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical intermediates market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest-growing market for pharmaceutical intermediates? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharmaceutical intermediates market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharmaceutical intermediates market; and compares it with other markets.

The report covers the following chapters

Introduction And Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by category, by application and by end-user.

Key Trends

Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.

Macro-Economic Scenario

The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmaceutical intermediates market.

Global Market Size And Growth

Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis

Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.

Market Segmentation

Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, segmentation by category, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.

Regional Market Size And Growth

Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Other Major And Innovative Companies

Details on the company profiles of other major and innovative companies

Competitive Benchmarking

Briefs on the financials comparison between major players in the market

Competitive Dashboard

Briefs on competitive dashboard of major players.

Key Mergers And Acquisitions

Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section includes recommendations for the pharmaceutical intermediates providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Product: Chemical Intermediate; Bulk Drug Intermediate; Other Products
2) By Category: Branded Drug Intermediate; Generic Drug Intermediate
3) By Application: Oncology Drugs; Anti-Infective Drugs; Central Nervous System Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs; Other Applications
4) By End-User: Biotech And Pharma Companies; Research Institutions; Other End-Users
Companies Mentioned: BASF SE; Evonik Industries AG; Pfizer Inc; Arkema Inc; Koninklijke DSM N.V.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical intermediates indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1048

1 Executive Summary

1.1 Pharmaceutical Intermediates - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Pharmaceutical Intermediates Market Definition And Segmentations
6.4 Market Segmentation By Product
- 6.4.1 Chemical Intermediate
- 6.4.2 Bulk Drug Intermediate
- 6.4.3 Other Products
6.5 Market Segmentation By Category
- 6.5.1 Branded Drug Intermediate
- 6.5.2 Generic Drug Intermediate
6.6 Market Segmentation By Application
- 6.6.1 Oncology Drugs
- 6.6.2 Anti-Infective Drugs
- 6.6.3 Central Nervous System Drugs
- 6.6.4 Respiratory Diseases Drugs
- 6.6.5 Cardiovascular Drugs
- 6.6.6 Musculoskeletal Disorders Drugs
- 6.6.7 Metabolic Disorders Drugs
- 6.6.8 Other Applications
6.7 Market Segmentation By End-User
- 6.7.1 Biotech And Pharma Companies
- 6.7.2 Research Institutions
- 6.7.3 Other End-Users

7 Major Market Trends

7.1 Innovative AI Solutions For Seamless Integration Of Drug Discovery And Synthesis
7.2 Strategic Partnerships And Acquisitions Among Market Players To Drive Innovation In The Market
7.3 Innovative Product Launches To Support The Evolution Of Safe And Effective Medicines
7.4 Focus On Production Facility Expansions
7.5 Quick Response (QR) Code Labelling To Track All Drug-Related Information
7.6 Focus On Green Chemistry To Reduce The Environmental Impact Of Synthetic Chemistry

8 Pharmaceutical Intermediates Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Pharmaceutical Intermediates Market
8.2 Impact Of The War In Ukraine On The Pharmaceutical Intermediates Market
8.3 Impact Of High Inflation On The Pharmaceutical Intermediates Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Pharmaceutical Intermediates Market Segmentation

10.1 Global Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.4 Global Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Pharmaceutical Intermediates Market, Regional and Country Analysis

11.1 Global Pharmaceutical Intermediates Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Pharmaceutical Intermediates Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.6 Asia-Pacific Pharmaceutical Intermediates Market: Country Analysis
12.7 China Market
12.8 Summary
12.9 Market Overview
- 12.9.1 Country Information
- 12.9.2 Market Information
- 12.9.3 Background Information
- 12.9.4 Government Initiatives
- 12.9.5 Regulations
- 12.9.6 Regulatory Bodies
- 12.9.7 Major Associations
- 12.9.8 Taxes Levied
- 12.9.9 Corporate Tax Structure
- 12.9.10 Investments
- 12.9.11 Major Companies
12.10 China Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 China Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.12 China Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Market
12.14 India Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 India Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.16 India Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Market
12.18 Japan Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.20 Japan Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Market
12.22 Australia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.24 Australia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Market
12.26 Indonesia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.28 Indonesia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Market
12.30 South Korea Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.32 South Korea Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate Tax Structure
- 13.2.10 Investments
- 13.2.11 Major Companies
13.3 Western Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Pharmaceutical Intermediates Market: Country Analysis
13.7 UK Market
13.8 UK Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 France Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major Companies
14.3 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Pharmaceutical Intermediates Market: Country Analysis
14.7 Russia Market
14.8 Russia Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 North America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Pharmaceutical Intermediates Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
15.10 USA Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Pharmaceutical Intermediates Market, Segmentation By Category, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 South America Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Pharmaceutical Intermediates Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Investments
- 17.2.11 Major Companies
17.3 Middle East Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Corporate Tax Structure
- 18.2.10 Investments
- 18.2.11 Major Companies
18.3 Africa Pharmaceutical Intermediates Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Pharmaceutical Intermediates Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Pharmaceutical Intermediates Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

19.1 Company Profiles
19.2 BASF SE
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 Evonik Industries AG
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 Pfizer Inc
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 Arkema S.A.
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Koninklijke DSM N.V.
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy
- 19.6.4 Financial performance

20 Other Major And Innovative Companies

20.1 Cambrex Corporation
- 20.1.1 Company Overview
- 20.1.2 Products And Services
- 20.1.3 Business Strategy
20.2 Lianhe Chemical Technology Co Ltd
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 Ercros, S.A.
- 20.3.1 Company Overview
- 20.3.2 Products And Services
- 20.3.3 Business Strategy
20.4 Lonza Group AG
- 20.4.1 Company Overview
- 20.4.2 Products And Services
- 20.4.3 1.4.3 Business Strategy
20.5 Codexis, Inc
- 20.5.1 Company Overview
- 20.5.2 Products And Services
- 20.5.3 Business Strategy
20.6 Actylis
- 20.6.1 Company Overview
- 20.6.2 Products And Services
- 20.6.3 Business Strategy
20.7 Kuraray Co., Ltd
- 20.7.1 Company Overview
- 20.7.2 Products And Services
20.8 Vertellus Holdings LLC
- 20.8.1 Company Overview
- 20.8.2 Products And Services
20.9 Hikal Ltd
- 20.9.1 Company Overview
- 20.9.2 Products And Services
20.10 WeylChem International GmbH
- 20.10.1 Company Overview
- 20.10.2 Products And Services
- 20.10.3 Business Strategy

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Hovione Acquired ExtremoChem
23.2 Noramco Acquired The Cambrex Drug Product Business Unit
23.3 Harmony Biosciences Acquired Zynerba Pharmaceuticals
23.4 UBE Acquired API Corporation
23.5 Cambrex Acquired Snapdragon Chemistry
23.6 Sekhmet Pharmaventures Acquired Optimus Drugs
23.7 SK Capital Partners Acquired A Majority Shareholding Of SEQENS
23.8 Aceto Corporation Acquired Cascade Chemistry
23.9 Wavelength Pharmaceuticals Acquired Vanamali Organics

24 Opportunities And Strategies

24.1 Global Pharmaceutical Intermediates Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Pharmaceutical Intermediates Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Pharmaceutical Intermediates Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Pharmaceutical Intermediates Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer